We announced entering into an agreement to acquire DR-0201, Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion. The acquisition, subject to closing conditions including receipt ...

Sanofi says it has reached an agreement with Dren Bio that would see it take control of autoimmune disease treatment DR-0201, a bispecific antibody-based myeloid cell engager with the potential to ...

Companies with new drug candidates continue to acquire others French pharmaceutical company Sanofi announced on the 20th (local time) that it has signed a contract to acquire the ‘DR-0201 ...

Under terms of the deal, Novo Nordisk will obtain global rights to develop, manufacture, and commercialize LX9851 for obesity and metabolic disorders. Novo Nordisk is expanding its obesity drug ...

Jennifer Kyle, CEO and founder of Condor, explores how improving financial management directly impacts drug pricing. In this Pharmaceutical Executive video interview, Jennifer Kyle, CEO and founder of ...

Could Kim Kardashian lose custody of her four kids? On the March 26 episode of the 2 Angry Men podcast, Dr. Phil said that Kardashian is at risk of exactly that if she doesn't keep them safe.

In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Sanofi (SNYNF – Research Report), with a price target ...